These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37867428)

  • 1. The Impact of CoronaVac Vaccination on 28-day Mortality Rate of Critically Ill Patients with COVID-19 in Türkiye.
    Gül F; Kasapoğlu US; Sabaz MS; Ay P; Oktay BD; Çalışkan G; Demir N; Sayan İ; Kabadayı F; Altuntaş G; Gümüş A; Kırca H; Şanlı D; Acil F; Dedeoğlu A; Ural SG; Akın Şen İ; Macit Aydın E; Dayanır H; Yelken B; Ceylan İ; Aydın OÖ; Eskidemir G; Aytekin A; Cengiz M; Arslan Ü; Akdağ D; Alay GH; Tekin E; Yarar V; Saracoğlu KT; Gök F; Alparslan V; Tuna V; Yıldız M; Şenoğlu N; Kıraklı C; Yıldırım S; Saçar Kübüç K; Erer A; Gültekin H; Özmen Süner K; Kuzgun Ö; Öztürk ÇE; Karahan A; Deveci O; Ay M; Tüfek Öztan D; Akıncı SB; Yalçın Solak M; Bozbay S; Özçiftçi S; Gönderen K; Küçük AO; Uyan B; Elay G; Boyacı N; Timurkaan M; Karakoç E; Doğan L; Yalçınkaya E; Kazancıoğlu L; Erdal Dönmez G; Yılmaz B; Ergül DF; Boran M; Özkarakaş H; Karakaş B; Ergin Özcan P; Anaklı İ; Bayar MK; Yüksel DY; Akdağ Ş; Pişkin Ö; Temur S; Eyüpoğlu S; Tekir Yılmaz E; Avcı GZ; Turan R; Alkan Bayburt F; Şahintürk H; Güçyetmez B; Alparslan MM; Yarıcı M; Yıldırım F; Yektaş A; Yaman G; Demirkıran O; Cinel İ
    Balkan Med J; 2023 Oct; 40(6):435-444. PubMed ID: 37867428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Sevinc SA; Metin S; Basi NB; Ling J; Cinar AS; Oba S
    Epidemiol Infect; 2022 Feb; 150():e35. PubMed ID: 35135644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination status among patients with the need for emergency hospitalizations related to COVID-19.
    Toker İ; Kılınç Toker A; Turunç Özdemir A; Çelik İ; Bol O; Bülbül E
    Am J Emerg Med; 2022 Apr; 54():102-106. PubMed ID: 35152117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers.
    Bayhan GI; Guner R
    Hum Vaccin Immunother; 2022 Dec; 18(1):2020017. PubMed ID: 35172694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
    Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
    Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study.
    Monteiro HS; Lima Neto AS; Kahn R; Sousa GS; Carmona HA; Andrade JS; Castro MC
    Vaccine; 2023 Sep; 41(39):5742-5751. PubMed ID: 37573202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
    Omma A; Batirel A; Aydin M; Yilmaz Karadag F; Erden A; Kucuksahin O; Armagan B; Güven SC; Karakas O; Gokdemir S; Altunal LN; Buber AA; Gemcioglu E; Zengin O; Inan O; Sahiner ES; Korukluoglu G; Sezer Z; Ozdarendeli A; Kara A; Ates I
    Hum Vaccin Immunother; 2022 Nov; 18(6):2122503. PubMed ID: 36315843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
    Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
    Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study.
    Kang W; Shami JJP; Yan VKC; Ye X; Blais JE; Li X; Lee VHF; Chui CSL; Lai FTT; Wan EYF; Wong CKH; Wong ICK; Chan EW
    J Hematol Oncol; 2022 May; 15(1):66. PubMed ID: 35590336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data.
    Copur B; Surme S; Sayili U; Tuncer G; Pehlivanoglu F; Sengoz G
    Future Microbiol; 2022 Nov; 17():1381-1391. PubMed ID: 36169346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical outcomes of vaccinated and unvaccinated patients with hospitalization for COVID-19.
    Ozdemir YE; Kizilcay B; Sonmezisik M; Tarhan MS; Borcak D; Sahin Ozdemir M; Bayramlar OF; Yesilbag Z; Senoglu S; Gedik H; Kumbasar Karaosmanoglu H; Kart Yasar K
    Acta Microbiol Immunol Hung; 2022 Dec; 69(4):270-276. PubMed ID: 36129790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
    Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
    Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
    Low EV; Tok PSK; Husin M; Suah JL; Tng BH; Thevananthan T; Appannan MR; Yahaya H; Mohd Zin S; Muhamad Zin F; Sivasampu S; Peariasamy KM
    JAMA Netw Open; 2022 Aug; 5(8):e2226046. PubMed ID: 35947381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between COVID-19 vaccination status in pregnancy and birthweight.
    Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of critically ill patients with one, two and three doses of vaccination against COVID-19 in Australia.
    Otto M; Burrell AJC; Neto AS; Alliegro PV; Trapani T; Cheng A; Udy AA;
    Intern Med J; 2023 Mar; 53(3):330-338. PubMed ID: 35841294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.